USE OF NIFURATEL TO TREAT INFECTIONS CAUSED BY CLOSTRIDIUM SPECIES

摘要

The present invention is directed to the use of nifuratel, or a physiologically acceptable salt thereof, to treat infections caused by bacteria species of the genus Clostridium. The invention is further directed to the use of nifuratel to treat Clostridium difficile infection (CDI) and in particular Clostridium difficile associated diarrhoea (CDAD).